Weekly Research Analysts’ Ratings Updates for CME Group (CME)

A number of firms have modified their ratings and price targets on shares of CME Group (NASDAQ: CME) recently:

• 3/16/2026 – CME Group had its price target raised by The Goldman Sachs Group, Inc. from $266.00 to $275.00. They now have a “sell” rating on the stock.
• 3/12/2026 – CME Group had its price target raised by Rothschild & Co Redburn from $333.00 to $347.00. They now have a “neutral” rating on the stock.
• 3/5/2026 – CME Group was upgraded by Erste Group Bank AG from “hold” to “strong-buy”.
• 3/4/2026 – CME Group had its “hold” rating reaffirmed by Argus.
• 3/2/2026 – CME Group was upgraded by Weiss Ratings from “buy (b+)” to “buy (a-)”.
• 3/2/2026 – CME Group had its price target raised by Jefferies Financial Group Inc. from $302.00 to $356.00. They now have a “buy” rating on the stock.
• 2/12/2026 – CME Group had its price target raised by Rothschild & Co Redburn from $300.00 to $333.00. They now have a “neutral” rating on the stock.
• 2/9/2026 – CME Group had its price target raised by The Goldman Sachs Group, Inc. from $264.00 to $266.00. They now have a “sell” rating on the stock.
• 2/6/2026 – CME Group had its “neutral” rating reaffirmed by UBS Group AG. They now have a $310.00 price target on the stock.
• 2/5/2026 – CME Group had its price target raised by TD Cowen from $305.00 to $328.00. They now have a “buy” rating on the stock.
• 2/5/2026 – CME Group had its price target raised by Morgan Stanley from $319.00 to $340.00. They now have an “overweight” rating on the stock.
• 2/5/2026 – CME Group had its price target raised by Barclays PLC from $304.00 to $312.00. They now have an “equal weight” rating on the stock.
• 2/5/2026 – CME Group had its price target raised by Deutsche Bank Aktiengesellschaft from $312.00 to $316.00. They now have a “buy” rating on the stock.
• 2/5/2026 – CME Group had its price target raised by JPMorgan Chase & Co. from $262.00 to $266.00. They now have an “underweight” rating on the stock.
• 2/5/2026 – CME Group had its price target raised by Royal Bank Of Canada from $295.00 to $302.00. They now have a “sector perform” rating on the stock.
• 2/4/2026 – CME Group had its price target lowered by Raymond James Financial, Inc. from $311.00 to $310.00. They now have an “outperform” rating on the stock.
• 1/22/2026 – CME Group had its price target raised by JPMorgan Chase & Co. from $256.00 to $262.00. They now have an “underweight” rating on the stock.

CME Group Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, March 26th. Stockholders of record on Tuesday, March 10th will be issued a dividend of $1.30 per share. The ex-dividend date of this dividend is Tuesday, March 10th. This is a positive change from CME Group’s previous quarterly dividend of $1.25. This represents a $5.20 annualized dividend and a dividend yield of 1.7%. CME Group’s dividend payout ratio is presently 46.59%.

Insider Activity at CME Group

In other CME Group news, Director Martin J. Gepsman sold 300 shares of the business’s stock in a transaction on Friday, February 20th. The shares were sold at an average price of $305.90, for a total transaction of $91,770.00. Following the completion of the sale, the director directly owned 24,999 shares in the company, valued at approximately $7,647,194.10. The trade was a 1.19% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director William R. Shepard purchased 251 shares of the stock in a transaction dated Tuesday, December 30th. The shares were purchased at an average cost of $278.37 per share, for a total transaction of $69,870.87. Following the completion of the acquisition, the director directly owned 258,710 shares in the company, valued at approximately $72,017,102.70. This trade represents a 0.10% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders have sold 8,539 shares of company stock valued at $2,713,821 over the last quarter. 0.30% of the stock is owned by company insiders.

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.